REJURAN® in the Australian aesthetics industry

K BRIDGE MEDICAL is the exclusive REJURAN DISTRIBUTOR in ANZ

REJURAN is a medical device included on the Australian Register of Therapeutic Goods (ARTG) as a dermal tissue reconstructive material (ARTG ID No. 412630 / 412631 / 412632). 

REJURAN is a sterile injectable gel containing sodium polynucleotide, placed into the dermis by a trained healthcare professional to support tissue restoration and an improved physical appearance. Treatment areas may include the face, including around the eyes and mouth. 

Unravelling the Science Behind REJURAN

What is PN (Polynucleotide)?

REJURAN is made of wild salmon polynucleotides (PN), DNA fragments of a defined size extracted using PharmaResearch's proprietary DNA Optimising Technology (DOT™). REJURAN is a clear, colourless, and viscous solution.

Upon injection, the PN is hydrating to cause volumetric increases of tissues and make more favourable physiological conditions for the growth of cells in the skin. 

IMPORTANT INFORMATION:

Always read the label and follow directions for use.

This product is not available for purchase by the general public and is intended for use by qualified healthcare professionals only. 

Consult a healthcare professional to determine if REJURAN is appropriate for your needs. Patient experience and results may vary.

Media Notes

Using the name ‘Rejuran ‘Sodium polynucleotide’ or ‘sodium DNA’ is not a substance included in Schedule 4 of the current Poisons Standard. Therefore, Rejuran can be advertised to consumers, using the trade name of the device, provided the advertisements comply with the relevant sections of the Therapeutic Goods Advertising Code and AHPRA Guidelines.

Media appointments to access Rejuran are available, contact Simone for further information.

Any opinions from media must be genuine and freely given. Noting such an article would be considered advertising of a therapeutic good, it would be required to be compliant with the relevant provisions of the Therapeutic Goods Advertising Code and AHPRA and MTAA guidance.  Also note that consumer media MUST NOT include doctors' endorsements/testimonials or quotes on Rejuran, they also must include the mandatory statement ‘Always read the label and follow directions for use’. Media can however name the treatment ‘Rejuran’ and talk of the clinic experience. 

For more information on REJURAN® please visit https://www.rejuran.com.au

For media enquiries, contact Simone Wyndham @beautyprsydney simone@kichi.com.au

About Pharma Research: Pharma Research is a leading innovator in the field of aesthetic medicine, dedicated to developing cutting-edge solutions that enhance and rejuvenate the skin. With a commitment to excellence, Pharma Research employs proprietary technologies to deliver safe and effective treatments, pushing the boundaries of skincare and beauty.